.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203313

« Back to Dashboard
NDA 203313 describes RYZODEG 70/30, which is a drug marketed by Novo Nordisk Inc and is included in one NDA. There are ten patents protecting this drug. Additional details are available on the RYZODEG 70/30 profile page.

The generic ingredient in RYZODEG 70/30 is insulin aspart; insulin degludec. There are thirty-eight drug master file entries for this compound. Additional details are available on the insulin aspart; insulin degludec profile page.

Summary for NDA: 203313

Tradename:
RYZODEG 70/30
Applicant:
Novo Nordisk Inc
Ingredient:
insulin aspart; insulin degludec
Patents:10
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;SUBCUTANEOUSStrength90 UNITS/3ML;210 UNITS/3ML (30 UNITS/ML;70 UNITS/ML)
Approval Date:Sep 25, 2015TE:RLD:Yes
Patent:5,866,538Patent Expiration:Jun 20, 2017Product Flag?YSubstance Flag?Delist Request?
Patent:6,899,699Patent Expiration:Jan 2, 2022Product Flag?YSubstance Flag?Delist Request?
Patent:7,615,532Patent Expiration:May 25, 2025Product Flag?YSubstance Flag?YDelist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc